Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Jitaian (Sichuan) Pharmaceutical is a Chengdu-based pharmaceutical company established in 1993 that specializes in the development and manufacture of Traditional Chinese Medicine (TCM) formulations. The company is most well-known for its expertise in addiction medicine, specifically its flagship product, the Jitai Capsule, which is an NMPA-approved herbal treatment for opioid detoxification and withdrawal management. Beyond its specialty in detoxification, Jitaian maintains a diverse portfolio of TCM patent medicines targeting cardiovascular health, respiratory ailments, and gynecological conditions. The company operates modern GMP-certified manufacturing facilities and distributes its products throughout clinical and retail markets in China. Jitaian continues to focus on integrating traditional formulas with modern pharmaceutical standards to treat chronic and complex diseases.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Jitaian (Sichuan) Pharmaceutical.